Publikationen von Anna-Leena Sirén

Zerche, M.; Weissenborn, K.; Ott, C.; Dere, E.; Asif, A. R.; Worthmann, H.; Hassouna, I.; Rentzsch, K.; Tryc, A. B.; Dahm, L. et al.; Steiner, J.; Binder, L.; Wiltfang, J.; Sirén, A.-L.; Stöcker, W.; Ehrenreich, H.: Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke. Stroke 46 (5), S. 1180 - 1186 (2015)

Byts, N.; Samoylenko, A.; Fasshauer, T.; Ivanisevic, M.; Hennighausen, L.; Ehrenreich, H.; Sirén, A.-L.: Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death and Differentiation 15, S. 783 - 792 (2008)

Samoylenko, A.; Byts, N.; Rajalingam, K.; von Ahsen, N.; Rapp, U. R.; Ehrenreich, H.; Sirén, A.-L.: Thrombopoietin inhibits nerve growth factor-induced neuronal differentiation and ERK signalling. Cellular Signalling 20, S. 154 - 162 (2008)

Ehrenreich, H.; Fischer, B.; Norra, C.; Schellenberger, F.; Stender, N.; Stiefel, M.; Sirén, A.-L.; Paulus, W.; Nave, K.-A.; Gold, R. et al.; Bartels, C.: Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. Brain 130 (10), S. 2577 - 2588 (2007)

Ehrenreich, H.; Hinze-Selch, D.; Stawicki, S.; Aust, C.; Knolle-Veentjer, S.; Wilms, S.; Heinz, G.; Erdag, S.; Jahn, H.; Degner, D. et al.; Ritzen, M.; Mohr, A.; Wagner, M.; Schneider, U.; Bohn, M.; Huber, M.; Czernik, A.; Pollmacher, T.; Maier, W.; Sirén, A.-L.; Klosterkötter, J.; Falkai, P.; Rüther, E.; Aldenhoff, J. B.; Krampe, H.: Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular Psychiatry 12 (2), S. 206 - 220 (2007)

Weishaupt, J. H.; Bartels, C.; Pölking, E.; Dietrich, J.; Rohde, G.; Poeggeler, B.; Mertens, N.; Sperling, S.; Bohn, M.; Hüther, G. et al.; Schneider, A.; Bach, A.; Sirén, A.-L.; Hardeland, R.; Bähr, M.; Nave, K.-A.; Ehrenreich, H.: Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research 41 (4), S. 313 - 323 (2006)

Byts, N.; Samoylenko, A.; Woldt, H.; Ehrenreich, H.; Sirén, A.-L.: Cell type specific signalling by hematopoietic growth factors in neural cells. Neurochemical Research 31 (10), S. 1219 - 1230 (2006)

Hasselblatt, M.; Ehrenreich, H.; Sirén, A.-L.: The brain erythropoietin system and its potential for therapeutic exploitation in brain disease. Journal of Neurosurgical Anesthesiology 18 (2), S. 132 - 138 (2006)

Sirén, A.-L.; Radyushkin, K.; Boretius, S.; Kämmer, D.; Riechers, C.-C.; Natt, O.; Sargin, D.; Watanabe, T.; Sperling, S.; Michaelis, T. et al.; Price, J.; Meyer, B.; Frahm, J.; Ehrenreich, H.: Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. Brain 129, S. 480 - 489 (2006)

Knabe, W.; Sirén, A.-L.; Ehrenreich, H.; Kuhn, H.-J.: Expression patterns of erythropoietin and its receptor in the developing spinal cord and dorsal root ganglia. Anatomy and Embryology 210, S. 209 - 219 (2005)

Unzicker, C.; Erberich, H.; Moldrich, G.; Woldt, H.; Bulla, J.; Mechoulam, R.; Ehrenreich, H.; Sirén, A.-L.: Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: A neuroprotective substitution effect ? Neurochemical Research 30 (10), S. 1305 - 1309 (2005)

Heyer, A.; Hasselblatt, M.; von Ahsen, N.; Häfner, H.; Sirén, A.-L.; Ehrenreich, H.: In vitro gender differences in neuronal survival on hypoxia and in 17 beta-estradiol-mediated neuroprotection. Journal of Cerebral Blood Flow and Metabolism 25 (4), S. 427 - 430 (2005)

Ehrenreich, H.; Hasselblatt, M.; Knerlich, F.; von Ahsen, N.; Jacob, S.; Sperling, S.; Woldt, H.; Vehmeyer, K.; Nave, K.-A.; Sirén, A.-L.: A hematopoietic growth factor, thrombopoietin, has a proapoptotic role in the brain. Proceedings of the National Academy of Sciences of the United States of America 102 (3), S. 862 - 867 (2005)

Ehrenreich, H.; Aust, C.; Krampe, H.; Jahn, H.; Jacob, S.; Herrmann, M.; Sirén, A.-L.: Erythropoietin: Novel approaches to neuroprotection in human brain disease. Metabolic Brain Disease 19 (3-4), S. 195 - 206 (2004)

Scheil, S.; Horn, T.; Kunz, U.; Gabelmann, A.; Sirén, A.-L.; Klein, R.; Schindler, C.; Möller, P.; Sommer, C.: Brain pathology case of the month - may 2004: Newborn with intracranial mass. Brain Pathology 14 (4), S. 455 - 456 (2004)

Ehrenreich, H.; Timner, W.; Siren, A.-L.: A novel role for an established player: anemia drug erythropoietin for the treatment of cerebral hypoxia/ischemia. Transfusion and Apheresis Science 31 (1), S. 39 - 44 (2004)

Weishaupt, J. H.; Rohde, G.; Polking, E.; Sirén, A.-L.; Ehrenreich, H.; Bähr, M.: Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells. Investigative Ophthalmology & Visual Science 45 (5), S. 1514 - 1522 (2004)

Piazza, O.; Siren, A. L.; Ehrenreich, H.: Soccer, neurotrauma and amyotrophic lateral sclerosis: is there a connection? Current Medical Research and Opinion 20 (4), S. 505 - 508 (2004)

Blomstrand, F.; Venance, L.; Sirén, A.-L.; Ezan, P.; Hanse, E.; Glowinski, J.; Ehrenreich, H.; Giaume, C.: Endothelins regulate astrocyte gap junctions in rat hippocampal slices. European Journal of Neuroscience: European Neuroscience Association 19 (4), S. 1005 - 1015 (2004)

Ehrenreich, H.; Degner, D.; Meller, J.; Brines, M.; Behe, M.; Hasselblatt, M.; Woldt, H.; Falkai, P.; Knerlich, F.; Jacob, S. et al.; von Ahsen, N.; Maier, W.; Bruck, W.; Rüther, E.; Cerami, A.; Becker, W.; Sirén, A.-L.: Erythropoietin: a candidate compound for neuroprotection in schizophrenia. Molecular Psychiatry 9 (1), S. 42 - 54 (2004)